pramipexole has been researched along with thyrotropin-releasing hormone in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (thyrotropin-releasing hormone) | Trials (thyrotropin-releasing hormone) | Recent Studies (post-2010) (thyrotropin-releasing hormone) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 27 | 0 | 6 |
| Protein | Taxonomy | pramipexole (IC50) | thyrotropin-releasing hormone (IC50) |
|---|---|---|---|
| Thyrotropin-releasing hormone receptor | Mus musculus (house mouse) | 0.0119 | |
| Thyroliberin receptor | Mus musculus (house mouse) | 0.007 | |
| Thyroliberin receptor | Rattus norvegicus (Norway rat) | 0.023 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for pramipexole and thyrotropin-releasing hormone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |